Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $2.4 million.

  • Biote's Share-based Compensation rose 734.97% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 267.92%. This contributed to the annual value of $8.7 million for FY2024, which is 355.53% down from last year.
  • As of Q3 2025, Biote's Share-based Compensation stood at $2.4 million, which was up 734.97% from $2.2 million recorded in Q2 2025.
  • Biote's 5-year Share-based Compensation high stood at $79.2 million for Q2 2022, and its period low was $56000.0 during Q1 2022.
  • In the last 5 years, Biote's Share-based Compensation had a median value of $2.1 million in 2022 and averaged $5.9 million.
  • In the last 5 years, Biote's Share-based Compensation soared by 8694835.16% in 2022 and then crashed by 9665.84% in 2023.
  • Quarter analysis of 5 years shows Biote's Share-based Compensation stood at $57000.0 in 2021, then soared by 3696.49% to $2.2 million in 2022, then fell by 7.72% to $2.0 million in 2023, then decreased by 5.56% to $1.9 million in 2024, then rose by 27.78% to $2.4 million in 2025.
  • Its Share-based Compensation stands at $2.4 million for Q3 2025, versus $2.2 million for Q2 2025 and $2.1 million for Q1 2025.